The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity
Patricia Ho(Columbia University Irving Medical Center), Benjamin Izar(Columbia University Irving Medical Center), Jana Biermann(Columbia University Irving Medical Center), Amit Dipak Amin(University of Cambridge), Jean‐Christophe Marine(VIB-KU Leuven Center for Cancer Biology), Parin Shah(Harvard University), Shivem B. Shah(Columbia University Irving Medical Center), Emily M. Mace(Columbia University Irving Medical Center), Mohsen Khosravi‐Maharlooei(Mayo Clinic in Arizona), Hijab Fatima(Columbia University), Samuel F. Bakhoum(Memorial Sloan Kettering Cancer Center), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Dirk Schadendorf(National Center for Tumor Diseases), Zachary Walsh(Columbia University Irving Medical Center), Oleksandr Kyrysyuk(Dana-Farber Cancer Institute), Johannes C. Melms(Columbia University Irving Medical Center), Steven L. Reiner(Columbia University Irving Medical Center), Chantale Bernatchez(BMC Software (United States)), Lindsay Caprio(Columbia University Irving Medical Center), Joanna Poźniak(VIB-KU Leuven Center for Cancer Biology), Benjamin T. Fullerton(Columbia University), Chris J. Frangieh(Columbia University Irving Medical Center), Megan Sykes(Columbia University Irving Medical Center), Meri Rogava(Columbia University Irving Medical Center), Casey R. Ager(Columbia University Irving Medical Center), Giorgia Zanetti(Columbia University), Michael Mu(Columbia University Irving Medical Center), Rajesh K. Soni(Columbia University), Emily K. Moore(Columbia University Irving Medical Center), Neil Vasan(Columbia University Irving Medical Center), Oliver Bechter(Universitair Ziekenhuis Leuven), Yi‐Ping Wang(National Taiwan University), Gary K. Schwartz(Baylor University Medical Center)
Cited by 93
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Nivolumab in Previously Untreated Melanoma without <i>BRAF</i> Mutation
|New England Journal of Medicine|2014|5.3k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
|New England Journal of Medicine|2014|3.5k
A view on drug resistance in cancer
|Nature|2019|2.7k